• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

22号染色体断点簇区域(bcr)中一种罕见的限制性内切酶位点多态性。

A rare restriction enzyme site polymorphism in the breakpoint cluster region (bcr) of chromosome 22.

作者信息

Benn P, Grossman A, Soper L, Halka K, Eisenberg A, Gascon P

机构信息

Lifecodes Corporation, Valhalla, New York 10595.

出版信息

Leukemia. 1988 Nov;2(11):760-2.

PMID:2903273
Abstract

Detection of rearrangement of the breakpoint cluster region (bcr) of chromosome 22 by Southern blot analysis can be used for the routine diagnosis of CML. Restriction fragment length polymorphisms (RFLPs) in the bcr can potentially be confused with translocation since both alter the size of DNA fragments obtained. By digesting DNA with the restriction enzyme BamHl and analyzing with probes commonly used for identifying rearrangement of the bcr, we have observed a RFLP within the bcr. For one CML patient studied in detail, the presence of the polymorphism was confirmed by comparing the results of analyses of granulocytes and a T cell-enriched population. The same polymorphism was detected in three additional CML patients and a patient with thrombocytosis. For the diagnosis of CML, verification of rearrangement with multiple probes and/or restriction enzyme combinations is necessary to rule out false positives, as well as to reduce the chance of false negatives due to co-migration of DNA fragments.

摘要

通过Southern印迹分析检测22号染色体断点簇区域(bcr)的重排可用于慢性粒细胞白血病(CML)的常规诊断。bcr中的限制性片段长度多态性(RFLP)可能会与易位混淆,因为两者都会改变所获得的DNA片段大小。通过用限制性内切酶BamH1消化DNA并用常用于鉴定bcr重排的探针进行分析,我们在bcr内观察到了一个RFLP。对于一名进行了详细研究的CML患者,通过比较粒细胞和富含T细胞群体的分析结果证实了多态性的存在。在另外三名CML患者和一名血小板增多症患者中也检测到了相同的多态性。对于CML的诊断,有必要用多种探针和/或限制性内切酶组合来验证重排,以排除假阳性,同时减少由于DNA片段共迁移导致假阴性的可能性。

相似文献

1
A rare restriction enzyme site polymorphism in the breakpoint cluster region (bcr) of chromosome 22.22号染色体断点簇区域(bcr)中一种罕见的限制性内切酶位点多态性。
Leukemia. 1988 Nov;2(11):760-2.
2
bcr rearrangement: potential false positive secondary to an Eco RI restriction fragment length polymorphism.BCR重排:因Eco RI限制性片段长度多态性导致潜在假阳性。
Leukemia. 1989 Oct;3(10):746-8.
3
Restriction fragment length polymorphism of bcr in Japanese patients with hematological malignancies.日本血液系统恶性肿瘤患者中bcr的限制性片段长度多态性
Leukemia. 1988 Oct;2(10):701-3.
4
Breakpoints in Philadelphia chromosome (Ph1)-positive leukemias.费城染色体(Ph1)阳性白血病的断点
Jpn J Cancer Res. 1987 Jun;78(6):590-5.
5
Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia.用于慢性粒细胞白血病中费城(Ph1)染色体易位的DNA探针检测法的临床评估
Leukemia. 1988 Oct;2(10):648-57.
6
Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.伴有非典型t(6;9)(p23;q34)易位的慢性髓性白血病的分子细胞遗传学
Leukemia. 1995 Jun;9(6):981-7.
7
Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.慢性髓性白血病(CML)中一种变异的费城染色体1易位t(9;22;11) (q34;q11;q13)的分子特征显示,BCR基因的3'端部分易位至染色体带11q13。 1 费城染色体(Philadelphia chromosome,Ph)是一种特异性染色体异常,在慢性髓性白血病中常见。
Oncogene. 1993 Dec;8(12):3239-47.
8
The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia.慢性髓性白血病中22号染色体断点簇区域(bcr)内断点的位置。
Leukemia. 1988 Oct;2(10):642-7.
9
Breakpoint cluster region (BCR) gene rearrangement studies in chronic myeloid and acute lymphoblastic leukemias.
Med J Malaysia. 1992 Jun;47(2):110-3.
10
[Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].[慢性粒细胞白血病无Ph染色体及伴异常Ph易位患者的细胞遗传学和分子研究]
Zhonghua Yi Xue Za Zhi. 1993 Apr;73(4):209-12, 252-3.

引用本文的文献

1
Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia.22号染色体断点簇区域(bcr)内断点的精细定位表明bcr外显子3在决定慢性粒细胞白血病疾病持续时间中起作用。
Am J Hum Genet. 1989 Nov;45(5):729-38.